These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32730886)

  • 1. Study on the mechanism of Gegen Qinlian Decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation.
    Xu X; Niu L; Liu Y; Pang M; Lu W; Xia C; Zhu Y; Yang B; Wang Q
    J Ethnopharmacol; 2020 Nov; 262():113129. PubMed ID: 32730886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of Gegen Qinlian decoction for normalizing hyperglycemia in diabetic patients: A systematic review and meta-analysis of randomized clinical trials.
    Ryuk JA; Lixia M; Cao S; Ko BS; Park S
    Complement Ther Med; 2017 Aug; 33():6-13. PubMed ID: 28735827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the synergistic mechanism of Gegen Qinlian Decoction on the Wnt signaling pathway using an integrated strategy of network pharmacology and RNA-seq.
    Li Y; Gong Y; Zhang X; Wang J; Cheng Y; Liu F; Shi X; Xu W; Dong L
    J Ethnopharmacol; 2021 Oct; 278():114283. PubMed ID: 34098017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the mechanism of modified Gegen Qinlian decoction in regulating the intestinal flora-bile acid-TGR5 axis for the treatment of type 2 diabetes mellitus based on macro genome sequencing and targeted metabonomics integration.
    Liu R; Wang J; Zhao Y; Zhou Q; Yang X; Gao Y; Li Q; Bai M; Liu J; Liang Y; Zhu X
    Phytomedicine; 2024 Sep; 132():155329. PubMed ID: 38853123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gegen Qinlian decoction activates PPARγ to ameliorate adipocytic insulin resistance in diabetic SD rats and IR-3T3-L1 adipocytes].
    Luo XX; Zhu SL; Li BT; Shi XM; Tu J
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(23):4641-4648. PubMed ID: 29376265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
    Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
    J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Ingredients and Mechanism of Gegen Qinlian Decoction in the Treatment of Diabetic Cardiomyopathy: A Network Pharmacology Study.
    Wang M; Liang Y; Qin Y; Ma R; Yu H; Wang W; Zhang X
    Curr Pharm Des; 2024; 30(36):2896-2910. PubMed ID: 39136516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-diabetic activities of Gegen Qinlian Decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T3-L1 adipocytes.
    Zhang CH; Xu GL; Liu YH; Rao Y; Yu RY; Zhang ZW; Wang YS; Tao L
    Phytomedicine; 2013 Feb; 20(3-4):221-9. PubMed ID: 23219338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compatibility mechanism of Gegen Qinlian Decoction in treatment of ulcerative colitis based on network pharmacology].
    Li T; Liu F; Zhang XY; Xu MS; Zhao Y; Sun J; Xu WJ; Dong L
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3619-3628. PubMed ID: 35850816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation.
    Bao W; Sun H; Wu X; Xu J; Zhang H; Cao L; Fan Y
    Dis Markers; 2022; 2022():1927688. PubMed ID: 36284987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
    Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
    J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota Are Attributable to Its Key Ingredient Berberine.
    Xu X; Gao Z; Yang F; Yang Y; Chen L; Han L; Zhao N; Xu J; Wang X; Ma Y; Shu L; Hu X; Lyu N; Pan Y; Zhu B; Zhao L; Tong X; Wang J
    Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):721-736. PubMed ID: 33359679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis.
    Wang W; Zhao L; He Z; Wu N; Li Q; Qiu X; Zhou L; Wang D
    J Ethnopharmacol; 2018 Jun; 219():299-318. PubMed ID: 29580854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology.
    Gao K; Yang R; Zhang J; Wang Z; Jia C; Zhang F; Li S; Wang J; Murtaza G; Xie H; Zhao H; Wang W; Chen J
    Pharmacol Res; 2018 Apr; 130():93-109. PubMed ID: 29391233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method to evaluate the dose-effect relationship of a TCM formula Gegen Qinlian Decoction: "Focus" mode of integrated biomarkers.
    Huang ZQ; Fan XM; Wang YM; Liang QL; Tong XL; Bai Y; Li YM; Luo GA; Chen C
    Acta Pharmacol Sin; 2017 Aug; 38(8):1141-1149. PubMed ID: 28317873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus.
    Pan L; Li Z; Wang Y; Zhang B; Liu G; Liu J
    J Ethnopharmacol; 2020 Aug; 258():112842. PubMed ID: 32333952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3/MAPK/NFATc1 signaling pathway based on cytokine antibody array.
    Yang J; He Q; Wang Y; Pan Z; Zhang G; Liang J; Su L; Wang A; Zeng C; Luo H; Liu L; Li J; Rao Q; Wang B; Wang H; Chen P
    Phytomedicine; 2022 Jan; 94():153810. PubMed ID: 34798519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of Fufang Fanshiliu decoction on type II diabetes mellitus by reducing insulin resistance: A comprehensive network prediction and experimental validation.
    Dai W; Chen C; Dong G; Li G; Peng W; Liu X; Yang J; Li L; Xu R; Hu X
    J Ethnopharmacol; 2022 Aug; 294():115338. PubMed ID: 35568115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and Gegen Qinlian Decoction boost islet α-cell proliferation of the STZ induced diabetic rats.
    Xu L; Jois S; Cui H
    BMC Complement Med Ther; 2022 Jul; 22(1):193. PubMed ID: 35858880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.